PRE 14A

SEC Filing Details

Document Details

Filing Date
Jun 29, 2017
Document Date
Jun 29, 2017
Form Description
A preliminary proxy statement providing notification matters to be brought to a vote
Filing Group
Proxy Filings
Company
Opiant Pharmaceuticals, Inc.
Issuer
LIGHTLAKE THERAPEUTICS INC.